Ownership history in XTX Topco Ltd · 12 quarters on record
This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in SUTRO BIOPHARMA INC (STRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 19,131 | -6,035 | -24.0% | 0.00% | $17K | $8.70 |
| 2025 Q1 | ADDED | 25,166 | +3,357 | +15.4% | 0.00% | $16K | $6.50 |
| 2024 Q4 | REDUCED | 21,809 | -82,391 | -79.1% | 0.00% | $40K | $18.40 |
| 2024 Q3 | ADDED | 104,200 | +71,844 | +222.0% | 0.03% | $361K | $34.60 |
| 2024 Q2 | REDUCED | 32,356 | -56,540 | -63.6% | 0.01% | $95K | $29.30 |
| 2024 Q1 | ADDED | 88,896 | +5,908 | +7.1% | 0.07% | $502K | $56.50 |
| 2023 Q4 | ADDED | 82,988 | +62,542 | +305.9% | 0.08% | $356K | $42.90 |
| 2023 Q3 | REDUCED | 20,446 | -80,336 | -79.7% | 0.01% | $71K | $34.70 |
| 2023 Q1 | REDUCED | 100,782 | -587 | -0.6% | 0.10% | $466K | $46.20 |
| 2022 Q4 | ADDED | 101,369 | +43,745 | +75.9% | 0.17% | $819K | $80.80 |
As of 2025 Q4 — sorted by position size